Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial - Auw Yang, K G; Raijmakers, N J; van Arkel, E R (Osteoarthritis Cartilage, 2008)
, et al.